May 11 |
Relmada Therapeutics, Inc. (NASDAQ:RLMD) Q1 2024 Earnings Call Transcript
|
May 10 |
Relmada Therapeutics, Inc. (RLMD) Q1 2024 Earnings Call Transcript
|
May 9 |
Relmada Therapeutics GAAP EPS of -$0.72 beats by $0.15
|
May 9 |
Q1 2024 Relmada Therapeutics Inc Earnings Call
|
May 9 |
Relmada Therapeutics Inc (RLMD) (Q1 2024) Earnings Call Transcript Highlights: Strategic ...
|
May 8 |
Relmada Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results
|
May 6 |
Relmada Therapeutics to Report First Quarter 2024 Financial Results and Host Conference Call and Webcast on May 8, 2024
|
Mar 21 |
Relmada Therapeutics: Run Up Into Results May Resume Following This Drop
|
Mar 20 |
Relmada Therapeutics, Inc. (NASDAQ:RLMD) Q4 2023 Earnings Call Transcript
|
Mar 20 |
Q4 2023 Relmada Therapeutics Inc Earnings Call
|